Table 1 Demographic and clinical characteristics of control and T2DM subjects
| Â | Controls | T2DM | P |
|---|---|---|---|
(n = 265) | (n = 326) | ||
Sex | |||
 Male, n (%) | 192(72.5) | 222(68.1) | 0.250 |
 Female, n (%) | 73(27.5) | 104(31.9) |  |
Age | 52.55 ± 10.11 | 53.52 ± 11.57 | 0.282 |
BMI (kg/m2) | 26.31 ± 3.63 | 27.07 ± 3.86 | 0.015 |
Smoking index | 300(0, 2400) | 40(0, 2400) | 0.003 |
Current smoking status | |||
 Never, n (%) | 87(32.8) | 156(47.9) | 0.001 |
 Former, n (%) | 35(13.2) | 33(10.1) |  |
 Current, n (%) | 143(54.0) | 137(42.0) |  |
HbA1c (%) | 5.54 ± 0.29 | 9.07 ± 2.22 | 0.000 |
FBG (mmol/L) | 4.91 ± 0.67 | 7.65 ± 2.66 | 0.000 |
HDL (mmol/L) | 1.15 ± 0.32 | 1.02 ± 0.25 | 0.000 |
LDL (mmol/L) | 2.82 ± 0.80 | 2.78 ± 0.92 | 0.580 |
TG (mmol/L) | 2.01 ± 1.44 | 2.16 ± 1.58 | 0.242 |
eGFR (ml/min/1.73m2) | 100.89 ± 11.48 | 105.46 ± 14.20 | 0.000 |